Why the study?
Is elevated ADMA associated with an increased risk of major cardiovascular events and mortality across diverse patient populations?
Is elevated ADMA associated with an increased risk of major cardiovascular events and mortality across diverse patient populations?
Elevated ADMA is a robust biomarker associated with an increased risk of major cardiovascular events and mortality across various clinical conditions.
No takes yet. Share an insight, caveat, or question.
May refine risk stratification across populations; hypothesis-generating and should not yet change practice.
Rainer H. Böger (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: